Skip to Main Content

Advertisement

Skip Nav Destination

Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma

Mol Cancer Ther (2021) 20 (1): 132–141.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Agnes Ewongwo
  • Caressa Hui
  • Everett J. Moding
Seminars in Radiation Oncology (2024) 34 (2): 195.
  • Patrick Schöffski
  • Rastislav Bahleda
  • Andrew J. Wagner
  • Melissa A. Burgess
  • Niels Junker
  • Michael Chisamore
  • Patrick Peterson
  • Anna M. Szpurka
  • Matteo Ceccarelli
  • William D. Tap
Clinical Cancer Research (2023) 29 (17): 3320.
  • Julie Blanchi
  • Audrey Laroche‐Clary
  • François Le Loarer
  • Benjamin Bonhomme
  • Antoine Italiano
Cancer Communications (2023) 43 (3): 391.
  • Chiara Agnoletto
  • Chiara Caruso
  • Cecilia Garofalo
Cancers (2021) 13 (9): 2189.
  • Javier Martín-Broto
  • Patrick M. Peterson
  • Gerard J. Oakley
  • Matteo Ceccarelli
  • Robin L. Jones
Molecular Cancer Therapeutics (2021) 20 (10): 2094.
  • Pia van der Laan
  • Winan J. van Houdt
  • Daan van den Broek
  • Neeltje Steeghs
  • Winette T. A. van der Graaf
Biomedicines (2021) 9 (10): 1315.
  • Serena Pillozzi
  • Andrea Bernini
  • Ilaria Palchetti
  • Olivia Crociani
  • Lorenzo Antonuzzo
  • Domenico Campanacci
  • Guido Scoccianti
Cancers (2021) 13 (12): 3044.
  • Vicente Valenti
  • Alberto Carmona-Bayonas
  • Paula Jimenez-Fonseca
  • Ramon Salazar
Molecular Cancer Therapeutics (2021) 20 (10): 2093.
Close Modal

or Create an Account

Close Modal
Close Modal